Skip to main content

Table 2 Predictors of log NT-proBNP in multivariate regression analysis

From: B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function

Variables

Predictors of log BNP

Predictors of log NT-proBNP

 

B standardized coefficient

Confidence Interval

p value

B standardized coefficient

Confidence Interval

p value

Age

0.055

−0.003 to 0.007

0.40

−0.108

−0.011 to 0.000

0.03

Creatinine

−0.030

−0.054 to 0.038

0.74

−0.079

−0.085 to 0.024

0.26

Body Mass Index

0.008

−0.014 to 0.031

0.46

0.104

0.003 to 0.053

0.02

Duration of kidney disease

0.095

0.000 to 0.004

0.12

−0.029

−0.003 to 0.002

0.53

Heart Failure

−0.134

−0.445 to 0.147

0.32

0.262

0.077 to 0.800

0.01

NYHA stage

0.075

−0.089 to 0.165

0.55

0.634

0.368 to 0.617

0.00

Ejection fraction

0.045

−0.008 to 0.010

0.76

0.138

−0.004 to 0.017

0.22

eGFR

0.070

−0.005 to 0.011

0.48

−0.468

−0.036 to −0.019

0.00

Log BNP/NT-proBNP

0.729

0.358 to 0.615

0.00

0.468

0.341 to 0.595

0.00

  1. Abbreviations: BNP b-type natriuretic peptide, NT-proBNP amino terminal B-type natriuretic peptide, NYHA New York Heart Association, eGFR estimated glomerular filtration rate, ARB angiotensin receptor blocker.
  2. p-value <0.05 statistically significant.